In contrast to most cytokines, interleukin 4 (II_,4) expression is restricted to T lymphocytes, with the exception of mast cell lines and mast cells, as more recently demonstrated in rodents. Little is known, however, about the capacity of human nonlymphoid cells to produce I1,4. In this study we show that mature human basophils are capable of expressing I1-4 and examine the regulation of I1.,4 production in comparison with the lipid mediator leukotriene C4. 11-4 was produced upon immunoglobulin E receptor (IgER) activation of basophils cultured with Ib3, a cytokine previously shown to prime these cells for enhanced release of inflammatory mediators. In some experiments, I1-3 or IgER activation alone also induced I1-4 production close to the detection limit. The effect of IL-3 on IgER-dependent I1,4 expression was dose and time dependent: maximal I1-4 production occurred between 18 and 48 h preexposure of basophils to 3-10 ng/ml I1.-3. IgER-induced I1.-4 synthesis and release by basophils cultured with Ib3 was rapid and complete after 6 h. In contrast to I1,3, other cytokines (I1,5, granulocyte/macrophage colony-stimulating factor, and nerve growth factor) that also prime basophils for enhanced histamine and leukotriene C4 release did not promote IgER-induced I1,4 synthesis. Basophils appear to secrete a "TH2-like" cytokine profile since no detectable I1,2 or interferon 3' was produced upon IgER activation. Mononuclear cells (depleted of basophils), cultured in parallel, did not release I1-4 in response to I1-3 and/or IgER activation, and produced approximately ten times less I1-4 than basophils upon nonspecific activation by phorbol ester and calcium ionophore. Thus, human basophils are an important cellular source of I1-4, and may, therefore, in addition to their inflammatory effector functions, also regulate the differentiation of T helper cells and B cells, in particular in allergic diseases.
From the Institute of Clinical Immunology, CH-3010 Bern, Switzerland; and "Ciba C, eig?, CH-4002 Basel, Switzerland
Summary In contrast to most cytokines, interleukin 4 (II_,4) expression is restricted to T lymphocytes, with the exception of mast cell lines and mast cells, as more recently demonstrated in rodents. Little is known, however, about the capacity of human nonlymphoid cells to produce I1, 4 . In this study we show that mature human basophils are capable of expressing I1-4 and examine the regulation of I1.,4 production in comparison with the lipid mediator leukotriene C4. 11-4 was produced upon immunoglobulin E receptor (IgER) activation of basophils cultured with Ib3, a cytokine previously shown to prime these cells for enhanced release of inflammatory mediators.
In some experiments, I1-3 or IgER activation alone also induced I1-4 production close to the detection limit. The effect of IL-3 on IgER-dependent I1,4 expression was dose and time dependent: maximal I1-4 production occurred between 18 and 48 h preexposure of basophils to 3-10 ng/ml I1.-3. IgER-induced I1.-4 synthesis and release by basophils cultured with Ib3 was rapid and complete after 6 h. In contrast to I1,3, other cytokines (I1,5, granulocyte/macrophage colony-stimulating factor, and nerve growth factor) that also prime basophils for enhanced histamine and leukotriene C4 release did not promote IgER-induced I1,4 synthesis. Basophils appear to secrete a "TH2-like" cytokine profile since no detectable I1,2 or interferon 3' was produced upon IgER activation. Mononuclear cells (depleted of basophils), cultured in parallel, did not release I1-4 in response to I1-3 and/or IgER activation, and produced approximately ten times less I1-4 than basophils upon nonspecific activation by phorbol ester and calcium ionophore. Thus, human basophils are an important cellular source of I1-4, and may, therefore, in addition to their inflammatory effector functions, also regulate the differentiation of T helper cells and B cells, in particular in allergic diseases.
I
1-4 is an immunoregulatory cytokine with a relatively restricted action on cells of the specific immune system, in contrast to most other cytokines with more pleiotrophic bioactivities. In most systems, the effects of I1-4 are antagonized by IFN-% and vice versa. IL-4 acts on T cells inducing T cell proliferation and differentiation into a TH2 phenotype (1) , and is of particular importance for the induction of IgE synthesis by providing an essential signal for isotype switching to IgE in human B cells (2, 3) . Furthermore, Ib4 has some inhibitory activities on monocyte function such as oxygen radical release and the synthesis of proinflammatory cytokines (4), and may be involved in the emigration of cells expressing very late antigen 4 (lymphocytes, eosinophils, and basophils) by inducing vascular cell adhesion molecule expression on endothelial cells (5) . Thus, the regulation of I1,4 synthesis appears to be a key element in the initiation and progression of allergic diseases.
In contrast to proinflammatory cytokines (e.g., II.,1, TNF, II.-8) which are produced by many cell types including tissue cells, the expression of cytokines with predominantly immunomodulatory bioactivities, such as II.,4, IFN-3,, and Ib2, is largely restricted to T cells. In rodents, Ib4 is also expressed (among other cytokines) by crosslinking of the immunoglobulin E receptor (IgER) 1 of immature bone marrow-derived mast cells and mast cell lines (6-8, for review see reference 9). In the human system, IgER-bearing bone marrow non-B, non-T cells (10) and most recently lung mast cells (10a) have been found capable of expressing II.-4. However, no blood leukocyte type other than lymphocytes has yet been identified to produce I1-4.
Mature human basophils are the only blood leukocyte type known to express the high-afEnity IgER (FceRI). The function of this cell type is strongly regulated by certain cytokines, II.,3, Ib5, GM-CSF, and nerve growth factor (NGF). A short preincubation (5-10 min) with one of these cytokines strongly enhances the release of inflammatory mediators in response to diverse agonists (11) (12) (13) . They also prime the basophils to produce leukotriene C4 (LTC4) in response to several agonists (e.g., C5a, monocyte-chemotactic peptide 1, Ib8, C3a, platelet-activating factor) which are otherwise inactive in this aspect (11) (12) (13) (14) (15) . Thus, lymphocyte products can qualitatively alter the function of these myeloid effector cells. Recently established methods for purifying this rare leukocyte type to near homogeneity have allowed us to examine direct long-term effects of cytokines on basophil functions. In particular, we investigated whether IgER crosslinking of mature human basophils can induce the expression of II:4 and whether this expression is under the control of certain cytokines.
Materials and Methods
Reagents and Media. The following were used: Hepes (Calbiochem-Behring Corp., La Jolh, CA); EDTA (Fluka AG, Buchs, Switzerland); Percoll and dextran (Pharmacia, Uppsala, Sweden); fatty acid-free BSA (Boehringer Mannheim, Mannheim, Germany); and actinomycin D and cycloheximide (Sigma Immunochemicals, St. Louis, MO). ALL other reagents were of the highest purity available. Hepes buffer contained 20 mM Hepes, 125 mM NaC1, 5 mM KC1, and 0.5 mM glucose. HA buffer was Hepes buffer containing 0.25 mg/ml BSA. Culture medium was RPMI 1640 supplemented with 10% FCS, 25 mM Hepes, 100 U/ml penicillin, and 100/zg/ml streptomycin, respectively, 2 mM nonessential amino acids, and 2 mM t-glutamine (Gibco, paisley, Scotland).
Pre~ration of Basophils and Mononuclear
Cells. Blood of unselected healthy volunteers was anticoagulated with 10 mM EDTA and mixed with 0.25 volumes of 6% dextran in 0.9% NaC1, and erythrocytes were allowed to sediment at room temperature. Leukocytes were pelleted by centrifugation (150 g, for 20 min at room temperature) and resuspended in isotonic Percoll solution with a density of 1.065 at '-2 x 107 cells/ml. 3 ml of cell suspension were layered on the top of a discontinuous PercoLL gradient consisting of 3 ml each of Percoll solutions with the densities 1.079 and 1.070 g/ml, respectively. Cells were centrifuged (400 g, for 30 rain at room temperature) and basophil-containing interphases between the densities 1.079 and 1.070 were harvested. For control experiments, the upper cell layers, containing lymphocytes, monocytes, and generally <0.5% basophils (mononuclear cells [MNC] ), were harvested as well and used in parallel under identical experimental conditions. Basophilenriched fractions (10-70% basophils) were washed twice in HA buffer and resuspended in 150 #1 HA buffer containing 1 mg/ml BSA at a cell density of 70-200 x 10 + cells/ml. Basophils were then further purified by negative selection using antibody-coated paramagnetic beads (depending on the composition of contaminating cell types: anti-CD4, 10-18 #1; anti-CD8, 8-15 #1; anti-CD19, 3-7/al; antiq2D14, 3-7 ~1; anti-CD16, 3-7/al; ~ system [Miltenyi Biotec, Bergisch Gladbach, Germany]) (16) . Basophil purity, as monitored by Giemsa-stained cytospin smears, generally ranged between 80 and 97%, the contaminating cells consisting mainly of small lymphocytes and occasionally few monocytes. Since the degree of contamination by monocytes and lymphocytes did not appear to influence Ib4 production under the experimental conditions of this study (see results), less pure basophil preparations of 50-80% were also used, and the results obtained were not excluded from data analysis.
Culture Conditions. Basophil preparations, and MNC (cultured in parallel for comparison), were resuspended at a cell density of 1.0-1.5 x 106 cells/ml in culture medium, incubated in sterile round bottomed 96-well microtiter plates (200/~l/weLL) (Becton Dickinson & Co., Lincoln Park, NJ) at 37~ in a humidified atmosphere with 5% CO2. Cells were exposed to the different reagents (added at a 0.5-1:100 vol/vol ratio). Cell-free supematants were then harvested after the time indicated and stored at -20~ until measurements of cytokine production by ELISA and sulfidoleukotriene synthesis by ILIA. In some experiments, cell pellets were lysed with 0.5% Nonidet in the original volume of culture medium and two freeze/thaw cycles after which cell debris were removed by high-speed centrifugafion.
Measurement of Cytoleines and Leukotriene C4/D4/E4. Ib4 was measured by ELISA as described (17, 18) . Briefly, microtiter plates were coated with mouse anti-hlb4 antibody 8F-12 and after incubation with samples or purified rhlL-4 plates were developed with the biotinylated mouse anti-hlb4 antibody 3H-4 followed by avidine-alkaline phosphatase conjugate (Calbiochem-Behring Corp.) which was revealed byp-nitrophenylphosphate disodium salt (Merck, Darmstadt, Germany). The assay had a sensitivity of 30 pg/ml with a dynamic range of up to 3 ng/ml. In some experiments, IL-4 was also measured using the kit supplied by R&D Systems (British Biotechnology Ltd., Oxford, UK) with similar results. Ib2 (R&D Systems) and IFN-3' (Genzyme Corp., Cambridge, MA) were measured with ELISA kits according to the manufacturer's protocols. Sulfidoleukotrienes were determined in a RIA as described (13) .
CellStimuli. rhIb3 and rhGM-CSF were a kind gift of Sandoz (Basel, Switzerland), and rhlb5 was from Amgen Biologicals (Thousand Oaks, CA) (11) . rhNGF was kindly provided by Genentech Inc. (South San Francisco, CA) (13) . Purified mAb 29C6, directed against the non-IgE-binding epitope of the high-affinity IgEK ~ chain (FceRI), was a generous gift from Drs. Hakimi and Chizzonite (Hoffmann-La Rrche, Nutley, NJ) (19) . PMA and ionomycin were from Sigma Immunochemicals. For all cytokines and stimuli, stock solutions were made in HA buffer containing 1 mg/ml BSA and 1-2 #1 were added to cell cultures. Ionomycin and PMA were solved in DMSO (final DMSO concentration
Results
Mature Human Basophils Produce 11,4. Fig. 1 
Dose Response for Priming and Triggering Human Basophils to
Express I/.,4. Fig. 2 demonstrates that ]I,3 primes basophils to secrete Ib4 in a dose-dependent manner. Consistent with Fig. 1 , zero to minimal amounts of IL-4 were detected after stimulation with czlgER alone. Only very low concentrations of Ib3 (1-3 ng/ml) were needed to allow optimal IgERdependent IL-4 production. The enhancement of c~IgER-induced LTC4 synthesis after overnight culture was also dose dependent, occurring over a similar concentration range of Ib3 (Fig. 2) . In another set of experiments, variable doses of cxlgER mAb were used to trigger basophils cultured during 18 h without or with a constant amount of IL-3. Again, de novo synthesis of lipid mediators and production of IL-4 occurred dose-dependently over an identical concentration range of o~IgER for both basophil effector functions (Fig. 3) . In these experiments, low levels of IL-4 expression were also detected after exposure to IL-3 alone, however in the absence of LTC4 generation. No IL-4 release was detected in unprimed basophfls in response to otIgER at 0.1-1,000 ng/ml (data not shown). Figs. 2 and 3 also demonstrate the inability of MNC prepared from the same blood donors to produce IL-4 under these experimental conditions. Fig. 4 shows the kinetic of czlgER-induced IL-4 production by human basophils. I1,4 synthesis and release by basophils cultured with IL-3 was very rapid and occurred within 2-6 h. No further increase of IL-4 release was observed between 6 and 24 h after odgER addition. By contrast, the kinetic of LTC4 synthesis (Fig. 4) and degranulation (12; data not shown) was clearly distinct since the release reaction of these inflammatory mediators was already complete 30 min after stimulation. These data indicate that IL-4 release in response to odgER is not 500 24 400. ~18 ~E 300-c _b~:> 12 O 0.1 1 10 100 1000 cdgER mad:) (ng/ml) due to a release reaction of preformed and granule-stored Ib4 that may have been synthesized during culture with IL-3. To further address this question, we examined IL-4 in culture supernatants as well as in lysed cell pellets ofbasophils treated with either buffer control, IL-3 or algER alone, or the sequential combination of both. Cell-associated Ib4 was only detected in IL-3 primed basophils exposed to algER stimulation, possibly representing Ib4 in a process of being secreted, but not in cell lysates under the other experimental conditions (data not shown). Furthermore, actinomycin, or cydoheximide (5/zg/ml) added to Ib3 primed cells just before IgER stimulation strongly suppressed Ib4 release (data not shown). Taken together, these results indicate that IL-4 secretion in response to IgER crosslinking of Ib3 primed basophils is due to de novo synthesis of IL-4.
Time Course of crlgER-induced II,4 Synthesis.

Human Basophils Produce a TH2-1ike Profile of CWkines. P,e-
cent studies in vitro and ex vivo have shown that Th cells can differentiate into subsets with a distinct capacity for producing different cytokines, in particular with regard to the expression of either II.-4 or IFN-'y and Ib2, respectively (1, (20) (21) (22) . Therefore, culture supernatants from representative experiments shown above were tested for the presence of IFN-~/or Ib2. Under none of the experimental conditions, including those resulting in I1.-4 release, did we detect any IFN-3~ or II.-2, whereas in culture supernatants of control MNC stimulated with PMA/ionomycin, large amounts of these cytokines were measured (data not shown).
vn~etct of Basophil-priming Cytokines on IgER-induced 11-.4
/on. Apart from IL,3, two other hematopoietic growth factors, Ib5 and GM-CSF, as well as the neurotrophic cytokines NGF have been shown to rapidly modify basophil mediator release in a way similar to Ib3. These cytokines were therefore tested for their ability to promote IgER-induced Ib4 production. Basophils were cultured overnight with these cytokines at concentrations maximally effective with regard to their priming activity for basophil mediator release, and then stimulated by IgER cross[inking for 6 h. Ib4 production was measured and compared with that of Ib3-treated basophils. Fig. 5 shows that Ib3 strongly primes basophils for IgER-induced Ib4 synthesis, whereas IL-5 and GM-CSF, as well as NGF were absolutely inactive in this respect.
Comparison of the Capacity to Produce 11.,4 in Response to Nonspeci.fic Activation between Human Peripheral Blood Basophils and MNC.
Since lymphocytes are a well-estabhshed source of Ib4, it was interesting to compare the general capacity of basophils and MNC to produce IL-4. Basophils, as well as MNC consisting of lymphocytes and monocytes and depleted of basophils (<0.5%), purified from the same blood specimens of different donors, were stimulated with PMA and ionomycin, a combination known to be a particular potent mode to induce cytokine expression in most cell types. Under these conditions, basophils produced Ib4 in amounts dearly exceeding that induced by IgER cross[inking of II.-3 primed basophils. It is striking that basophils produced nearly one order of magnitude more IIA than MNC under identical conditions, further emphasizing that basophils may represent a particularly important source of Ib4 among different Figure 6 . Comparison of the capacity to produce IL-4 between basophils and MNC. Basophils and MNC, isolated from the same blood specimen of different donors were stimulated for 24 h with a combination of PMA (5 ng/ml) and ionomycin (1/~M) and lb4 released in the supernatant was measured. Mean values _+ SD of four experiments performed in duplicates are shown. blood leukocyte types (Fig. 6) . Furthermore, stimulation of basophils with ionomycin alone resulted in II,4 production as well, comparable to that induced by sequential stimulation by IL-3 and odgER, whereas that produced by MNC was low and close to the detection limit (data not shown).
Diacuuion
Basophils are an important source of vasoactive and proinflammatory mediators that are released from granule stores (e.g., histamine) or de novo synthesized (e.g., leukotrienes) upon stimulation with IgE-dependent or -independent agonists. This study shows that mature human peripheral blood basophils cultured with IL-3 are also capable of producing substantial amounts of IL-4 upon crosslinking of the high-at~nity IgER. Although basophil preparations were not purified to 100% homogeneity, several lines of evidence indicate that indeed mature basophils were the source of Ib4 released under the experimental conditions of this study. Basophils are the only PBL known to express the high-affinity IgER, and lb4 was produced in response to stimulation with a mAb specific to the c~ chain of the FceRI. IgER-dependent IL-4 production was only observed in Perco11 fractions enriched in basophils, independent of the degree of contamination with leukocyte types other than basophils, and never in MNC depleted of basophils. Although we cannot exclude the existence of IgER-bearing nongranulated "non-B, non-T cells" in the peripheral blood capable of producing IL-4, such cells would be expected to accumulate in the PercoLl fraction of lower density rather than in the fraction containing granulated basophils. Mature human basophils consistently produced Ib4 after culture with IL-3 for 18-42 h upon crosslinking of the IgER. In some experiments, Ib4 was also detected in supernatants of cells cultured with either Ib3, and less frequently, with odgER alone, possibly because both ligands by themselves can induce low levels of IL-4 expression near the detection limit of the assay. Alternatively, cells of certain individuals may need only one of the two signals.
Ib3 primed the human basophils for IgER-dependent Ib4 synthesis dose-dependently at low concentrations (0.1-10 ng/ml). This dose range is similar to that previously found to enhance basophil mediator release and prime the cells for LTC4 synthesis in response to appropriate agonists (11, 12) . Two other hematopoietic growth factors, GM-CSF and Ib5, as well as a neurotrophic cytokine, NGF, have been found capable of rapidly modifying the basophil response in an identical manner to Ib3 with regard to histamine release and leukotriene generation (11) (12) (13) . Basophils carry high-a~nity receptors for Ib3, IL-5, and GM-CSF with variable degrees of competition of binding among these three growth factors (23, and our own unpublished results), due to a common high-affinity converter/signal transducer (KH97/gp120) receptor/3 chain for IL-3, Ib5, and GM-CSF (24, 25) . It is interesting that only ceils cultured with Ib3, but not with GM-CSF, IL-5, or NGF, were able to synthesize and release Ib4 in response to IgER crosslinking. This difference in the cytokine profile capable of rapidly priming basophils for LTC4 synthesis on the one hand, and priming the calls for Ib4 production after prolonged culture on the other, suggests that in addition to the common/3 chain, the cytokine-specific o~ chain may also participate in signal transduction for these hematopoietic growth factors, particularly regarding the later occurring downstream events regulating gene expression. Alternatively, basophil priming for II.,4 synthesis may require a critical amount of occupied receptors, higher than that necessary for enhancing the release of inflammatory mediators, and thus the unique property of IL-3 may be due to different receptor densities for these hematopoietic growth factors (23) .
The fact that 11,3, apart t~om potentiating basophil mediator release, also regulates the expression of the immunomodulatory cytokine IL,4 in this cell type, suggests that Ib3 may have an important function in the pathogenesis of immediatetype hypersensitivity diseases. Indeed, recent in situ hybridization studies of allergic late-phase reactions show that IL-3 is expressed possibly by activated TH2 helper cells (26) . Furthermore, eosinophils have been shown to express, at least upon calcium ionophore stimulation, hematopoietic growth factors (e.g., II.-3, Ib5, GM-CSF) which may act in an autocrine manner (27, 28) . The capacity of eosinophils to express Ib3 that regulates basophil functions may also represent a link of interaction between these effector cell types in allergic inflammatory exudates.
The regulation of Ib4 expression in human basophils was not investigated in detail. Our data indicate that IgER activation of Ib3 primed basophils induces the release of Ib4 by de novo synthesis. It is unlikely that Ib3 by itself induces the synthesis of Ib4 that is stored in the cell granules and released upon receptor stimulation. Cell-associated IL-4 was detected only in IL-3 primed cells after IgER crosslinking, presumably representing the fraction of IL-4 in the process of being secreted, but not in basophils exposed to Ib3 alone, and the protein synthesis inhibitor cycloheximide or the RNA synthesis inhibitor actinomycin, added after IL-3 culture and just before IgER stimulation abolished Ib4 release without affecting leukotriene synthesis. However, it is unclear whether Ib3 and odgER act synergistically by an identical mechanism on transcription, RNA stability and/or translation, or whether these events are regulated separately by these two signals.
IgER-induced Ib4 production by Ib3 primed basophils occurred rapidly and was completed within 6 h. IL-4 release was, however, clearly slower and distinct from the very rapid degranulation response and synthesis of LTC4, further dissociating these cellular responses. The amount of Ib4 produced by basophil within 6 h after IgER. stimulation was comparable to that produced by PHA-activated MNC within 24 h (our unpublished observations). It is also interesting to note that activation ofbasophils by a combination ofphorbol ester and calcium ionophore, a particularly potent mode of cytokine expression in most cell types, results in a considerably higher II:4 release than stimulation of the MNC fraction under identical conditions, further emphasizing the high potential of human basophils to express I1.-4.
Whereas most cytokines can be produced by many different cell types, the expression of IL-4, Ib2, and IFN-3~ is more restricted to the lymphocyte lineage. In the rodent system, certain mast cell lines, IL3-dependent cell lines, and bone marrow-derived mast cells have been shown to express Ib4, among other less restricted cytokines (6) (7) (8) (9) , mainly on the level of gene expression with little information about product release. Even less is known about the capacity of human mucosal and connective tissue-type mast cells to express and release cytokines. Skin mast cells have been shown to express TNF-ot (29) and a recent paper indicates that human lung mast cells can produce Ib4 (10a). The profile of cytokines regulating mediator release by human basophils and mucosal lung mast cells suggests that the human basophils are functionally more related to mouse mucosal mast cells than they are to human mucosal mast cells (30) . Thus, further studies are needed to define the importance ofbasophils or mast cells, respectively, as a source of Ib4 or other cytokines in the human system.
An increasing number of studies, including our own, indicate that the cells of the adaptive immune system strongly regulate the effector functions of granulocytic cells of the innate immune system in an antigen-independent manner by the release of different cytokine profiles (e.g., Ib3, II.-5 of TH2 cells regulating eosinophil and basophil functions). On the other hand, recent studies indicate that myeloid inflammatory effector cells can express several cytokines as well, and may thus influence the function of the adaptive immune system. With regard to Ib4 expression, however, the basophil appears to be the only yet identified nonlymphoid leukocyte type capable of producing this important immunoregulatory cytokine. The capacity of basophils to rapidly produce Ib4, in the absence of detectable Ib2 and IFN-3~ expression, indicates that this cell type, apart from its inflammatory effector function, also regulates the maturation and differentiation of T cells (differentiation into TH2 phenotype) (1, 31) and B cells (IgE switch) (2) . Thus, basophils may also represent immunomodulatory cells involved in the propagation and possibly even the initiation of immediate-type hypersensitivity disease, or also in the pathogenesis of infectious diseases with inadequate TH1 cell-mediated protective immunity (31) .
